Form 4 for DVA DaVita
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-12 · accession 0000927066-25-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-14 | 2025-03-12 | DVA | ACKERMAN JOEL | CFO, Treasuer | A - Grant | $0.00 | +14.6K | 134.8K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-12 | A | A | 7,221 | $0.00 | 142,069 | D | — | — | (F2) Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2022, of which 100% will vest on March 15, 2025. |
| 2 | Common | Common Stock | 2025-03-12 | A | A | 7,394 | $0.00 | 134,848 | D | — | — | (F1) Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2021, of which 100% will vest on March 15, 2025. |